Effectiveness in prevention of clotting in the extracorporeal circuit during hemodialysis 4 weeks (12 consecutive sessions) [clinicaltrials_resource:319aedac9bb6d10808ebd6e501aec254]
5000 UI/mL
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Effectiveness in prevention of clotting in the extracorporeal circuit during hemodialysis 4 weeks (12 consecutive sessions) [clinicaltrials_resource:319aedac9bb6d10808ebd6e501aec254]
5000 UI/mL
Bio2RDF identifier
319aedac9bb6d10808ebd6e501aec254
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:319aedac9bb6d10808ebd6e501aec254
measure [clinicaltrials_vocabulary:measure]
Effectiveness in prevention of clotting in the extracorporeal circuit during hemodialysis
time frame [clinicaltrials_vocabulary:time-frame]
4 weeks (12 consecutive sessions)
description
5000 UI/mL
identifier
clinicaltrials_resource:319aedac9bb6d10808ebd6e501aec254
title
Effectiveness in prevention of ...... eeks (12 consecutive sessions)
@en
type
label
Effectiveness in prevention of ...... aedac9bb6d10808ebd6e501aec254]
@en